Treatment of Interstitial Nephritis
The first-line treatment for interstitial nephritis is corticosteroid therapy, with prednisone 0.5-1 mg/kg/day for mild-moderate cases and methylprednisolone 1-2 mg/kg/day IV for severe cases, along with immediate discontinuation of the offending agent. 1, 2
Diagnostic Approach
Before initiating treatment, confirm the diagnosis and exclude other causes:
- Rule out other causes of acute kidney injury (hypovolemia, medication toxicity, obstruction, IV contrast)
- Check serum creatinine (elevation ≥50% from baseline)
- Perform urinalysis (look for sterile pyuria, hematuria, proteinuria)
- Consider renal ultrasound to exclude obstruction
- Consider renal biopsy in severe or atypical cases to confirm diagnosis
Treatment Algorithm
Step 1: Immediate Management
- Discontinue the suspected offending agent (most commonly antibiotics, PPIs, NSAIDs) 3
- Ensure adequate hydration
- Temporarily hold immune checkpoint inhibitors if applicable 1
Step 2: Corticosteroid Therapy Based on Severity
Grade 1 (Creatinine 1.5-2.0× baseline):
- Consider temporarily holding medications
- Monitor creatinine weekly 1
- If no improvement, treat as Grade 2
Grade 2 (Creatinine 2-3× baseline):
Grade 3-4 (Creatinine >3× baseline or >4.0 mg/dL):
Step 3: For Steroid-Resistant Cases
If no improvement after 1-2 weeks of corticosteroid therapy or worsening despite therapy:
- Consider additional immunosuppression with:
Monitoring and Follow-up
- Monitor serum creatinine weekly until stabilization 1, 2
- Continue monitoring during steroid taper
- Consider nephrology consultation for severe cases or those not responding to initial therapy 1
Prognostic Factors
- Early initiation of corticosteroids is associated with better renal function recovery 6
- Presence of interstitial fibrosis on biopsy indicates poorer response to steroids 6
- Neutrophilic predominance in biopsy is associated with favorable response 6
Special Considerations
- Diabetes mellitus may be associated with poorer response to steroids 6
- Avoid re-exposure to the causative agent due to high risk of recurrence 2
- For immune checkpoint inhibitor-related interstitial nephritis, permanent discontinuation of therapy may be necessary for Grade 3-4 nephritis 1
Common Pitfalls to Avoid
- Delaying corticosteroid initiation (early treatment improves outcomes)
- Inadequate duration of steroid therapy (taper over at least 4 weeks)
- Failure to identify and discontinue the offending agent
- Overlooking other potential nephrotoxic medications
- Tapering steroids too rapidly, which may lead to relapse
Both oral prednisolone and IV pulse methylprednisolone have shown similar efficacy in treating drug-induced interstitial nephritis when used early, so the choice depends on the severity of the case 4.